BACKGROUND: Pressure-volume (PV) loops provide a wealth of information on cardiac function but are not readily available in clinical routine or in clinical trials. This study aimed to develop and validate a noninvasive method to compute individualized left ventricular PV loops.
Seemann et al; Noninvasive Pressure-Volume Loops From CMR S afe and reliable tools for diagnosis and assessment of cardiac function are crucial for the treatment of cardiovascular disease and the evaluation of efficacy of treatment in clinical trials. Cardiac function can be described by ventricular changes in pressure and volume, and the pressure-volume (PV) relation can be visualized as a closed loop (PV loop). PV loops contain information of the whole heartbeat's function and work in a comprehensible visual overview that is taught early on in medical schools. Routinely used parameters, such as ejection fraction (EF), are accessible through the PV loop. Furthermore, PV loop analysis enables quantification of stroke work (SW) and contractility-clinically important aspects of ventricular function inaccessible by other methods. 1, 2 The information accessible through PV loop analysis has also been pointed out as critical when proving clinical relevance of new cardiovascular research and of having clinical utility. [3] [4] [5] A problem in the acquisition of PV loop measurements is that absolute pressure can only be reliably obtained by invasive catheterization, unlike volumes where noninvasive imaging techniques are readily available. [6] [7] [8] Today, simultaneous recordings of pressure and volume are, therefore, usually achieved by invasive PV conductance transducers. 9 However, invasive left ventricular (LV) catheterizations carry risk, and thus the risk-benefit has to be considered carefully for each individual patient. 1 A noninvasive method for PV loop estimation would be desirable, both as a surrogate end point in clinical trials 10 and as a tool to improve the characterization of cardiac function in clinical routine.
One way of estimating ventricular pressure is by calculation of ventricular volume and time-varying elastance. 11 The shape of the elastance curve is essentially consistent irrespective of cardiac health and loading conditions in a variety of mammals. 9, 11, 12 An approximation of the elastance curve shape can be represented mathematically 13 using the double-Hill equation, 14 which has been used as a source in closed-loop cardiovascular models. [14] [15] [16] However, the parameters determining the shape of the double-Hill equation have not been optimized from in vivo-measured elastance but rather estimated from the literature. 16 There have been additional attempts toward deriving elastance noninvasively. [17] [18] [19] [20] However, to the best of our knowledge, there is no validated noninvasive method to obtain individualized PV loops. A validation against measured PV loops is needed for a model-based method to gain acceptance for clinical or research purposes.
In this study, we hypothesized that it is possible to accurately estimate LV PV loops noninvasively using an elastance model with ventricular volume, heart rate, and brachial pressure as input. The aims of this study were (1) to develop and validate a model-based framework for noninvasive PV loop estimation using cardiovascular magnetic resonance (CMR) images and brachial blood pressure, (2) to optimize the double-Hill equation parameters using elastance from an experimental porcine model, and (3) as a proof-of-concept, to apply the model to healthy controls and patients with heart failure to analyze intergroup differences of PV loop-derived quantitative hemodynamic parameters.
METHODS
The data supporting the findings of this study are available from the corresponding author on reasonable request, within limits of the ethical permits of the study. Additionally, the proposed method is available on request for research collaboration.
Experimental Protocol
A visualization of the experimental protocol is illustrated in Figure I in the Data Supplement. Twelve pigs were included in the study and divided into a training and validation set.
The training set consisted of 5 healthy female pigs weighing 66±5 kg. LV pressures and volumes were simultaneously recorded for 0.1-4.5 minutes using a PV conductance catheter (Transonic, Ithaca, NY), inserted via the carotid artery. The training set was retrospectively included from a previous set of experiments and was used for double-Hill parameter optimization.
The validation set consisted of 7 pigs (3 female) weighing 47±7 kg. Of these, 2 were examined 7 days after myocardial infarction, which was experimentally induced via a percutaneous insertion of a balloon in the left anterior descending artery followed by a 40-minute occlusion, according to a previously described method. 21 The remaining 5 pigs were healthy, of which 2 were examined at baseline and at 2-week follow-up. Hence, a total of 9 data points were available for the validation. Validation animals underwent CMR and invasive LV catheterization using either a PV conductance (Transonic) or a fluid-filled catheter, inserted through the
CLINICAL PERSPECTIVE
Pressure-volume loop analysis enables an extensive interpretation of cardiac physiology. Currently used pressure-volume loop measurements are invasive in nature, thus limiting their use. In this study, we introduce a noninvasive method for pressure-volume loop estimation, which may be implemented both as a surrogate end point in clinical trials, as well as a tool to improve the characterization of cardiac function in clinical routine. Noninvasive pressure-volume loop analysis enables quantification of stroke work and contractility-clinically important aspects of ventricular function inaccessible by other methods. Hence, the proposed method potentially expands the armamentarium for individualized diagnostics and treatment in a wide range of patients.
femoral artery at each examination. Pressure was recorded for 3 to 17 minutes. Noninvasive cuff sphygmomanometry was acquired in the tail thrice, simultaneously to catheterization. Anesthesia was maintained on isoflurane gas, where a stable anesthesia was achieved and maintained before CMR and throughout blood pressure measurements after CMR. Care was taken to not introduce any vasoactive drugs or analgesia because this could have hemodynamic effects at the time of measurement.
Short-axis cine steady-state free-precession images covering the LV were acquired in a 1.5T Siemens (Siemens, Erlangen, Germany) CMR scanner, with retrospective ECG gating at end-expiratory breath hold. Images were acquired with typical spatial resolution of 1.5×1.5×8 mm and 25 reconstructed time frames. Typical temporal resolution was 31 ms; echo time, 1.1 ms; flip angle, 60°; and field of view, 270×320 mm 2 .
All animal experiments were approved by the regional ethics committee on animal experiments.
Study Population
Previously published human data from 13 healthy controls 22 and 28 patients with heart failure 23 were included. The study was approved by the regional ethics review board in Lund, Sweden, and all subjects gave informed written consent.
Brachial systolic and diastolic blood pressures from cuff sphygmomanometry and CMR short-axis cine steady-state free-precession images covering the LV were acquired. CMR was performed in a 1.5T or 3T scanner (Philips Healthcare, Best, the Netherlands) using retrospective ECG gating at end-expiratory breath hold. Typical spatial resolution was 1.5×1.5×8 mm and 30 reconstructed time frames. Typical repetition time was 2.9 ms; echo time, 1.4 ms; and flip angle, 60°.
Data Analysis
Images were analyzed using Segment 2.1 R5752 (http://segment.heiberg.se). 24 LV endocardial borders were semiautomatically delineated over the entire cardiac cycle (typically 30 time frames), with manual corrections performed as necessary, especially in the most basal slices (Figure 1 ). Cardiac cycle duration (T cycle ) was established from the CMR images. Endsystolic time (T ES ) was defined as the time at minimum ventricular volume and end-diastolic time (T ED ) at maximum volume.
LV pressure data were analyzed using customized software. Each heartbeat was automatically identified, and the mean pressure curve of all heartbeats was used as reference ( Figure 2 ). The reference pressure curve was synchronized so that the steepest negative slope occurred simultaneously with T ES . The maximum value in the reference pressure defined the peak systolic LV pressure (LVP systole ), and the last data point defined the peak diastolic LV pressure (LVP diastole ). Mean systolic and diastolic tail pressures were used as reference for noninvasive pressures, respectively.
Process Overview
An overview of the methodology is illustrated in Figure 3 . Model input is ventricular volume and heart rate obtained from CMR and noninvasive cuff pressure. The time-varying elastance model is scaled by the input and used to calculate ventricular pressure, thus allowing a PV loop as output. The process uses 2 approximations and assumptions: (1) LVP systole is approximated from brachial cuff pressure and (2) LVP diastole is estimated as a pressure range by the user. A sensitivity analysis of the impact of these approximations is provided.
Time-Varying Elastance Model
The time-varying elastance E(t) represents the increase and decrease of myocardial stiffness and is defined as
where P(t) is pressure, V(t) is volume, and V 0 is the ventricular volume at zero pressure.
In this study, a model of the time-varying elastance was expressed by the double-Hill equation.
14 Parameters determining the shape of the double-Hill were optimized using experimental data from the training set (Data Supplement). In short, in vivo elastance curves were derived from 875 invasively measured PV loops, and the double-Hill parameters yielding the best approximation to each heartbeat were identified using an optimization algorithm. 25 Elastance curve amplitude was defined by LVP systole and LVP diastole . Peak aortic pressure can be approximated to LVP systole . 26 Hence, LVP systole was approximated from brachial pressure according to an expression proposed by Kelly et al,
where SBP is systolic blood pressure, and DBP is diastolic blood pressure.
No approximation of LVP diastole from CMR or brachial pressure is available, which is why the user is prompted to estimate a range of LVP diastole , and all integer values within the range are used in the calculations. With V 0 approximated to zero, 17, 18, 28 ventricular pressure was calculated as
allowing the PV loop to be visualized by plotting V(t) against P(t). The volume-time curve V(t) was interpolated to 100 points before model application.
Hemodynamic Parameters
Several hemodynamic parameters can be derived from the PV loop. SW is the area enclosed by the PV loop and corresponds to the external work performed by the myocardium to eject blood. The mechanical potential energy (PE) is the internal energy that the heart overcomes to eject blood. 29 It can be quantified as the area between the end-systolic PV relations (ESPVR) and end-diastolic PV relations and the leftmost side of the PV loop ( Figure 4 ). Hence, ventricular mechanical energy consumption during 1 heartbeat is calculated as the PV area, PVA=SW+PE (4) which is approximately proportional to myocardial oxygen consumption. 30 The beat-to-beat ventricular efficiency (η) can be quantified as follows:
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The mean external power (MEP) that the LV delivers can be expressed as follows:
The ESPVR and end-diastolic PV relations intercept the x axis at V 0 and the PV loop at end systole and end diastole, respectively. Hence, PE was approximated by a triangle defined by the ESPVR, the end-systolic volume, and the x axis ( Figure 4 ).
The ESPVR slope is a measure of myocardial contractility and corresponds to the maximum elastance ( Figure 1A ). Myocardial compliance is the slope of the end-diastolic PV relations, 29 corresponding to the minimum elastance. The energy per ejected volume (EEV) is calculated as EEV= PVA SV (7) where SV is the stroke volume.
Experimental Validation
Validation was performed by comparing model-calculated SW, PE, and efficiency to invasive PV loops. LVP systole was derived from noninvasive tail pressures according to Equation 2, and LVP diastole was set to 5 mm Hg. Further, we investigated the LVP systole estimation from the tail pressures compared with invasively measured LVP systole . The agreement between the in vivo-measured and model-calculated elastance curves was calculated as Euclidean norm between the 2 curves. The norm of value zero corresponds to complete overlap of the curves, but there is no upper limit to the value of the norm.
Sensitivity Analysis
To determine the influence of the user-estimated LVP diastole , a sensitivity analysis was performed by varying LVP diastole over 0 to 15 mm Hg in the porcine validation set, while keeping all other parameters fixed. Invasive and model-derived SW, PE, and efficiency were compared and presented as bias±SD.
Similarly, the sensitivity with regard to LVP systole was analyzed. The parameter was ranged as the invasively measured LVP systole ±10 mm Hg.
Application in Healthy Controls and Patients
The model was applied to healthy controls and patients with heart failure. SW, PE, efficiency, MEP, contractility (ie, maximum elastance, the ESPVR slope), and EEV were calculated, with LVP systole approximated from brachial pressures. Each hemodynamic parameter was calculated for all LVP diastole integer values in the range of 0 to 15 mm Hg and presented as the mean hemodynamic parameter for each subject.
Further, end-systolic volume was compared with PE, and EF was compared with SW, η, MEP, E max , and EEV in all subjects. 
Implementation
The proposed method was implemented as a plugin in the software Segment 24 and is available on request for research collaboration. Figure II in the Data Supplement shows the plugin user interface.
Statistical Analysis
Statistical analysis was performed in GraphPad Prism 7.03 (GraphPad Software, Inc, La Jolla, CA). Intraclass correlation coefficient, 95% CIs, and Bland-Altman analysis were used to describe agreement between quantitative methods. Pearson or Spearman correlations (R, ρ) were reported. Level of agreement was considered poor for intraclass correlation coefficient in the range of 0.00 to 0.30, weak between 0.31 and 0.50, moderate between 0.51 and 0.70, strong between 0.71 and 0.90, and excellent between 0.91 and 1.00. 31 Differences between controls and patients were tested with a Mann-Whitney U test, with P <0.05 indicating statistical significance. Area under the curve (AUC) was calculated for the parameters with significant differences. Left ventricular (LV) volume and heart rate (HR) are obtained from cardiovascular magnetic resonance and peak systolic LV pressure from brachial pressure. The elastance is modeled by this input data. LV pressure P(t) is calculated using the elastance E(t) and volume V(t), enabling the visualization of the pressure-volume loop.
RESULTS
Three model-calculated PV loops are shown in Figure 5 . One loop is derived from the experimental part of the study and shown together with its corresponding in vivo-measured data, whereas the other 2 show the mean PV loops derived from healthy controls and patients with heart failure, respectively.
Experimental Validation
Approximation of LVP systole from tail pressure compared with invasively measured LVP systole is shown in Figure 6 and yielded a strong agreement and low bias and variability of −4.3±4.0 mm Hg. The agreement between model-calculated hemodynamic parameters compared with in vivo measurements was excellent for SW, moderate for PE, and strong for ventricular efficiency, as shown in Figure 7 . There was a small Euclidean norm between the in vivo-measured and model-calculated elastance curves, 1.3±0.6 (mean±SD). An example of an in vivo-measured and model-calculated elastance curve is shown in Figure III in the Data Supplement.
Sensitivity Analysis
Value ranges and error of SW, PE, and efficiency when varying LVP diastole and LVP systole are presented in Tables 1  and 2 , respectively. All hemodynamic parameters show a narrow range and low error. The most sensitive parameter was SW, which is shown in Figure IV in the Data Supplement.
Application in Healthy Controls and Patients
Subject characteristics are summarized in Tables 3  and 4 . Results from model application on both cohorts are presented in Table 5 . Further, the mean of each hemodynamic parameter for each subject over the LVP diastole range is shown in Figure 8 . Ventricular efficiency and contractility was lower in patients compared with controls, whereas PE and EEV were higher in patients. SW and MEP did not differ between the cohorts. The AUC values of the parameters that differed between the cohorts were as follows: PE, AUC=0.98 (95% CI, 0.94-1.02); efficiency, AUC=0.99 (95% CI, 0.97-1.0); contractility, AUC=0.93 (95% CI, 0.86-1.0); and EEV, AUC=0.99 (95% CI, 0.96-1.0). Figure V Bottom row shows 2 mean model-generated pressure-volume loops; healthy controls in blue and patients with heart failure in red. Note that the blue and red loops are represented with the same end-diastolic pressure of 7.5 mm Hg, to minimize assumptions of this user-estimated parameter in the model. If invasively measured end-diastolic pressures were used, the enddiastolic pressure of the heart failure loops would be expected to be higher compared with healthy controls.
DISCUSSION
This study introduces and validates the first method to derive PV loops noninvasively. The method requires a standard cuff-measured blood pressure, LV volume from CMR, and one user-estimated parameter. The estimated parameter is shown to have a small impact on the derived PV loop, and the method creates PV loops that correspond well with invasive measures in an animal model. Hence, the method has an advantage over invasive PV loops, which enable assessment of many important hemodynamic parameters 2 but are not recommended for repeated application in humans. 1 Currently, EF is one of the most used noninvasively measured parameters for evaluation of cardiac health. Even though a reduced EF is a strong indicator of heart failure, approximately half of all patients with heart failure present with preserved EF. In these cases, additional information on cardiac function can be found not only in the shape and position of the PV loop in the PV plot but also in the quantification of, for example, total energy consumption, contractility, and compliance of the myocardial tissue. Therefore, PV loops allow for a more comprehensive analysis of a patient's cardiac function compared with sole volumetric efficiency measurement of EF. Although not established in this study, for future studies on larger and more diversified patient cohorts, we hypothesize that our proposed PV loop analysis method may add valuable information relative to measures that are currently in clinical use. For example, noninvasive PV loops could impact the physiological characterization of energetic efficiency in patients with heart failure present with preserved EF, ventricular work load in hypertensive disorders, and contractility in patients who experienced myocardial infarction or other diseases affecting contractility. Contractility is a loadindependent measure only assessable with PV loops.
In this study, the model demonstrated well-known differences between PV loops and its associated hemodynamic parameters in healthy controls and patients with heart failure, such as the difference in ventricular efficiency, which is in line with previous results. 32, 33 Ventricular efficiency was strongly correlated to EF, which suggests that efficiency may only supply limited additional information on global cardiac function compared with EF. Nevertheless, although EF is defined by the volumetric variation of the ventricle, efficiency and total energy consumption are defined by both pressure and volume. This means that a patient with a normal EF can still have an elevated energy consumption if the blood pressure is high. Furthermore, the parameters PE, contractility (ie, the ESPVR slope), and EEV had a lower correlation to EF and differed significantly between the cohorts. Although the cohorts in this study were too distinct to be able to define a generalized cutoff value to distinguish controls and patients in other studies, all parameters that differed between the cohorts also had high AUC values. Although future studies will have to establish the prognostic value of these hemodynamic parameters, the high AUC values further underscore that the proposed model enables a noninvasive computation of valuable hemodynamic parameters that could potentially be used both clinically and in longitudinal clinical trials where repeated invasive cardiac catheterization is not recommended and as surrogate end points in clinical trials.
Parameters found to not be suitable surrogate end points by this study were SW and MEP. Although both parameters had a low correlation to EF, they did not differ between the cohorts. This was expected for SW, and the quantified SW values confirm results found by Arbab-Zadeh et al. 34 The explanation of the lack of difference for MEP lies in its definition as the product of SW and heart rate because heart rate also did not differ between controls and patients.
The proposed method did not only derive hemodynamic parameters as expected. The obtained PV loops were also physiologically representative when applied to humans, although the method was optimized on data acquired in pigs. This emphasizes the remarkable consistency of the time-varying elastance curve shape between mammals, 9, 11, 12 as well as its load independence. 11 The use of in vivo data as input to subject-specific cardiovascular models, which simulate pressure and volume has been proposed for various purposes in both the left 19, 35 and right ventricle. 36, 37 A noninvasive method to derive pressure-strain loops as a regional assessment of myocardial work has also been proposed. 38 Recently, Casas et al 20 presented a proof-of-concept model where a majority of the parameters, including the double-Hill parameters, were optimized by comparing simulations to 4D flow CMR data. However, to the best of our knowledge, no previous work has optimized double-Hill parameters from in vivo-derived elastance or experimentally validated the PV loops obtained using a noninvasive elastance model. The double-Hill parameters proposed in this study differ slightly from those proposed previously, 16 which is because of the fact that we performed the optimization based on in vivo data rather than derived from values published in literature. Another novelty was the fact that we chose a new optimization approach of the diastolic time parameter τ 2 . We allowed τ 2 to depend on the end-systolic time instead of the cardiac cycle time because the duration of diastole varies for different heart rates. The pathogenesis of IHD was determined by a significant presence of myocardial scar, quantified by CMR imaging with late gadolinium enhancement. ACE indicates angiotensin-converting enzyme; ARB, angiotensin II receptor blocker; CMR, cardiovascular magnetic resonance; DCM, dilated cardiomyopathy; IHD, ischemic heart disease; and LBBB, left bundle branch block. The sensitivity analysis on LVP systole revealed relatively low error and variability compared with invasively derived PV loops. Furthermore, our results showed that estimation of LVP systole from tail pressures compared with invasive measurements yielded a strong agreement and low bias. Approximation of LVP systole from cuff sphygmomanometry was, however, proposed based on a study on humans, 27 and the interchangeability of porcine tail pressure and human brachial pressure is unknown. The precision of the noninvasive LVP systole approximation could potentially be improved using calibrated applanation tonometry. 40 Nevertheless, it is still more common to measure brachial pressure than wave forms. Brachial pressure was, therefore, considered a more clinically applicable input, at a potential cost of accuracy. The importance of using a proper cuff size to get accurate blood pressures 41 is worth mentioning because the brachial pressure data is a key input to the model. When varying LVP diastole within 0 to 15 mm Hg, the sensitivity analysis exhibited a low influence on the model-calculated hemodynamic parameters, both regarding the value ranges and when comparing with in vivo-measured values. In future work, it is possible that the need of this user-estimated parameter could be eliminated by estimation of LV filling pressure using echocardiography, 42 ,43 which would also allow an estimate of myocardial compliance by measuring the end-diastolic PV relations slope and possibly the calculation of the LV capacitance index V 30 (the predicted LV volume at an end-diastolic pressure of 30 mm Hg). 44 The magnitude of LVP diastole was, however, not estimated in this study.
LIMITATIONS
A limitation in this study is that the time-varying elastance assumes a straight line from V 0 to each corresponding point of time in the PV loops, 11 although they are slightly convex. 45 Previous studies have approximated V 0 to zero, 17, 18, 28 as did we, although V 0 actually varies over time and is subject specific. 28 Methods for determining V 0 from a single heartbeat have been proposed but require both volume and pressure data recordings. 12 However, despite these limitations, validation showed a good agreement between in vivo and model-calculated hemodynamic parameters in pigs. Also, although the derivation of the ESPVR as a measure of contractility depends on the fixed value of V 0 , Heerdt et al 44 recently showed a 100% concordance between experimentally measured and simulated contractility using a fixed V 0 .
Although intraventricular pressure should ideally be recorded simultaneously to CMR imaging, pressure recording was performed in a catheterization laboratory within 3 hours of scanning because our catheterization equipment was not MR compliant. The separation of imaging and blood pressure measurements reflects the reality of clinical routine, and the low sensitivity of the parameter LVP systole indicates that the method is applicable even when blood pressure is not obtained immediately in conjunction with CMR. This further underscores the applicability of the method to obtain PV loops in a realistic setting, both on prospective and retrospective data if CMR and brachial pressure data are available.
A further limitation is that in patients with aortic stenosis, reliable determination of LVP systole from brachial pressure is currently not possible because these patients have a pressure gradient not accounted for by the model. This might be circumvented by estimating the pressure drop based on velocity measurements. None of the patients had any signs of aortic stenosis, so the added uncertainty effects of pressure drop measurements remain to be investigated. Special care will also be needed when applying the method on patients with atrial fibrillation, both with regard to the estimation of end-diastolic pressure, which in absence of the atrial kick will be the pressure at diastasis, as well as for the quality of the CMR data because fibrillation might result in triggering issues that can compromise the image quality and, therefore, the volume quantification. Atrial fibrillation does, however, not impact the determination of systolic function, such as contractility, because the measurement is intrinsically load independent.
In conclusion, this study presents the first fully noninvasive, experimentally validated method to estimate LV PV loops, using a time-varying elastance model with optimized double-Hill equation parameters from in vivo-derived elastance curves. The model produces accurate subject-specific PV loops and associated quantitative hemodynamic parameters without the need for invasive measurements.
